Helmholtz-Institute for Biomedical Engineering, Stem Cell Biology and Cellular Engineering, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Medical School, Aachen, Germany.
Institute for Biomedical Technology-Cell Biology, RWTH Aachen University Medical School, Aachen, Germany.
J Bone Miner Res. 2018 Feb;33(2):356-361. doi: 10.1002/jbmr.3298. Epub 2017 Oct 23.
Osteoporosis is an age-related metabolic bone disease. Hence, osteoporotic patients might suffer from molecular features of accelerated aging, which is generally reflected by specific age-associated DNA methylation (DNAm) changes. In this study, we analyzed genomewide DNAm profiles of peripheral blood from patients with manifest primary osteoporosis and non-osteoporotic controls. Statistical analysis did not reveal any individual CG dinucleotides (CpG sites) with significant aberrant DNAm in osteoporosis. Subsequently, we analyzed if age-associated DNAm patterns are increased in primary osteoporosis (OP). Using three independent age-predictors we did not find any evidence for accelerated epigenetic age in blood of osteoporotic patients. Taken together, osteoporosis is not reflected by characteristic DNAm patterns of peripheral blood that might be used as biomarker for the disease. The prevalence of osteoporosis is age-associated-but it is not associated with premature epigenetic aging in peripheral blood. © 2017 American Society for Bone and Mineral Research.
骨质疏松症是一种与年龄相关的代谢性骨病。因此,骨质疏松症患者可能患有加速衰老的分子特征,这通常反映在特定的与年龄相关的 DNA 甲基化(DNAm)变化上。在这项研究中,我们分析了表现为原发性骨质疏松症和非骨质疏松症对照患者外周血的全基因组 DNAm 图谱。统计分析并未发现骨质疏松症中有任何单个 CG 二核苷酸(CpG 位点)存在明显异常的 DNAm。随后,我们分析了原发性骨质疏松症(OP)中是否存在与年龄相关的 DNAm 模式增加。使用三个独立的年龄预测因子,我们没有发现骨质疏松症患者血液中存在加速表观遗传年龄的任何证据。综上所述,外周血中没有反映骨质疏松症的特征性 DNAm 模式,这些模式可能被用作该疾病的生物标志物。骨质疏松症的患病率与年龄相关,但与外周血中过早的表观遗传衰老无关。